Justices reject Johnson & Johnson appeal of $2B talc verdict
The Supreme Court is leaving in place a $2 billion verdict in favor of women who say they developed ovarian cancer from using Johnson & Johnson talc products.
Share:
More Stories
0:33
US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case
128ds ago
Nobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
394ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
406ds ago
Murphy administration: No plans to implement any COVID-19 restrictions
412ds ago0:39
Cape May hospital asking patients to wear mask amid COVID surge
413ds ago2:57
Lawmakers call for investigation, overhaul following DOJ report about NJ’s COVID response in veterans homes
415ds ago0:33
US Supreme Court rejects appeal on Rutgers University COVID-19 vaccine mandate case
128ds agoNobel in medicine goes to 2 scientists whose work enabled creation of mRNA vaccines against COVID-19
394ds ago0:21
Biden administration announces $600M to produce COVID tests and will reopen website to order them
406ds agoMurphy administration: No plans to implement any COVID-19 restrictions
412ds ago0:39
Cape May hospital asking patients to wear mask amid COVID surge
413ds ago2:57
Lawmakers call for investigation, overhaul following DOJ report about NJ’s COVID response in veterans homes
415ds agoThe Supreme Court is leaving in place a $2 billion verdict in favor of women who say they developed ovarian cancer from using Johnson & Johnson talc products.
The justices did not comment Tuesday in rejecting Johnson & Johnson's appeal.
VACCINE INFORMATION: Check to see if you
are eligible
APPOINTMENT INFORMATION: Where and how to get
vaccinated
SEARCH FOR A CURE: Statistics and State Resources
The New Jersey-based company argued it was not treated fairly in facing one trial involving 22 cancer sufferers who came from 12 states and different backgrounds.
A Missouri jury initially awarded the women $4.7 billion, but a state appeals court dropped two women from the suit and reduced the award to $2 billion.
The jury found the company’s talc products contain asbestos and asbestos-laced talc can cause ovarian cancer. The company disputes both points.
More from News 12
Dodgers win World series with 7-6 comeback victory in Game 5 against Yankees
1:10
Game 5 closes out home season at Yankee Stadium
1:03
Jersey Proud: Branchville to name winners of townwide scarecrow contest
0:16
Officials: Father-son duo from New Jersey face charges related to Jan. 6 Capitol riot
0:14
Prosecutor: Rutgers student accused of recording women in the shower
0:18
